B CELL LYMPHOMA (BCL)

Clinical trials for B CELL LYMPHOMA (BCL) explained in plain language.

Never miss a new study

Get alerted when new B CELL LYMPHOMA (BCL) trials appear

Sign up with your email to follow new studies for B CELL LYMPHOMA (BCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells take on stubborn lymphoma

Disease control Recruiting now

This study tests a new approach using a mix of gene-modified immune cells (CAR-T cells) that target multiple proteins found on B cell lymphoma cells. The goal is to see if this combination is safe and can shrink tumors in patients whose cancer has not responded to standard treatm…

Matched conditions: B CELL LYMPHOMA (BCL)

Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

B CELL LYMPHOMA (BCL)

Get alerted when new B CELL LYMPHOMA (BCL) trials appear

Engineered immune cells take on stubborn lymphoma